Skip to main content
. 2019 Feb 2;115(5):854–868. doi: 10.1093/cvr/cvz026

Figure 7.

Figure 7

Imaging findings from ICI-associated pericardial disease. cMRI of the heart demonstrating focal myocardial delayed gadolinium enhancement in the mid-lateral wall and mild late enhancement of the pericardium along the lateral wall suggestive of myopericarditis. The patient is a 70-year-old male who had received six doses enoblituzumab (an IgG antibody against B7-H3).